Have you experienced pain and/or injury from the drug Gadolinium? Mass Tort Resources can help!
Gadolinium is a paramagnetic metal ion. Paramagnetic ions, such as gadolinium, are beneficial in medical tests which use magnetic resonance imaging, commonly referred to as an “MRI”.
Gadolinium-based contrast agents (GBCAs) are made through a process in which large organic molecules form a stable complex around the gadolinium. The idea is to reduce the possibility of toxic exposure by making the Gadolinium more stable.
GBCAs are approved by FDA for use in imaging studies using MRI’s as a contrast agent to provide better images of internal bodily organs and tissue.
The most common contrast agent for MRI’s is gadolinium. However, various side effects occurred in patients with kidney disease. Many of these patients developed a disease called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD) – diseases that can produce areas of skin thickening that can be itchy and/or painful.
Other serious side effects connected to the Gadolinium contrast agent include,
- Burning, itching, swelling, and tightening of the skin
- Raised yellow patches on eyes
- Red or darkened skin patches, papules or plaque
- Muscle weakness
- Sharp bone pain
- Hardening of internal organs
- Inability or difficulty walking, extending arms, legs, hands or feet
- Kidney failure
- Renal failure
In June 2006, the Food and Drug Administration warned doctors and health care providers to screen patients for kidney problems before using any Gadolinium contrast agents for MRI’s.
In May 2007 the FDA issued a “black box” warning, the highest warning which can be placed on a medication, to alert patients and health care providers of potentially serious side effects and life threatening risks.